Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oriana Hoi Yun Yu

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Diabetes Care|May 15, 2023
Metformin and Cancer: Solutions to a Real-World Evidence FailureOriana Hoi Yun Yu, Samy Suissa
Canadian Journal of Diabetes|April 5, 2015
The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and deathOriana Hoi Yun Yu, Hui Yin, Laurent Azoulay
Canadian Journal of Diabetes|April 5, 2017
The Influence of Proton-Pump Inhibitors on Glycemic Control: A Systematic Review of the Literature and a Meta-AnalysisJuan C Gómez-Izquierdo, Oriana Hoi Yun Yu
Diabetes, Obesity & Metabolism|October 10, 2019
Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort studyAntonios Douros, Sophie Dell'Aniello, Oriana Hoi Yun Yu, et al.
Journal of Scleroderma and Related Disorders|June 8, 2023
Occupation as a gendered-role and outcome in systemic sclerosisFatema Alkhamees, Oriana Hoi Yun Yu, Mianbo Wang, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 24, 2014
Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitusJean-Pascal Fournier, Hui Yin, Oriana Hoi Yun Yu, et al.
Expert Opinion on Drug Safety|September 11, 2024
Comparative risk of infection of medications used for type 2 diabetesEstefania Zapata-Bravo, Antonios Douros, Oriana Hoi Yun Yu, et al.
Case Reports in Endocrinology|July 6, 2019
A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 DiabetesKimya Hassani-Ardakania, Mark L Lipman, Denny Laporta, et al.
Case Reports in Endocrinology|February 25, 2021
Corrigendum to "A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes"Kimya Hassani-Ardakani, Mark L Lipman, Denny Laporta, et al.
Pharmacoepidemiology and Drug Safety|October 8, 2024
The Prevalent New-User Design to Study Drug-Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe HypoglycemiaWanqi Wang, Ying Cui, Oriana Hoi Yun Yu, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Diabetes Care|May 15, 2023
Metformin and Cancer: Solutions to a Real-World Evidence FailureOriana Hoi Yun Yu, Samy Suissa
Canadian Journal of Diabetes|April 5, 2015
The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and deathOriana Hoi Yun Yu, Hui Yin, Laurent Azoulay
Canadian Journal of Diabetes|April 5, 2017
The Influence of Proton-Pump Inhibitors on Glycemic Control: A Systematic Review of the Literature and a Meta-AnalysisJuan C Gómez-Izquierdo, Oriana Hoi Yun Yu
Diabetes, Obesity & Metabolism|October 10, 2019
Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort studyAntonios Douros, Sophie Dell'Aniello, Oriana Hoi Yun Yu, et al.
Journal of Scleroderma and Related Disorders|June 8, 2023
Occupation as a gendered-role and outcome in systemic sclerosisFatema Alkhamees, Oriana Hoi Yun Yu, Mianbo Wang, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 24, 2014
Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitusJean-Pascal Fournier, Hui Yin, Oriana Hoi Yun Yu, et al.
Expert Opinion on Drug Safety|September 11, 2024
Comparative risk of infection of medications used for type 2 diabetesEstefania Zapata-Bravo, Antonios Douros, Oriana Hoi Yun Yu, et al.
Case Reports in Endocrinology|July 6, 2019
A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 DiabetesKimya Hassani-Ardakania, Mark L Lipman, Denny Laporta, et al.
Case Reports in Endocrinology|February 25, 2021
Corrigendum to "A Case of Severe Acute Kidney Injury Exacerbated by Canagliflozin in a Patient with Type 2 Diabetes"Kimya Hassani-Ardakani, Mark L Lipman, Denny Laporta, et al.
Pharmacoepidemiology and Drug Safety|October 8, 2024
The Prevalent New-User Design to Study Drug-Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe HypoglycemiaWanqi Wang, Ying Cui, Oriana Hoi Yun Yu, et al.
Pageof 4